Clinical trials in children

Lancet

Volumn 364, Issue 9436, 2004, Pages 803-811

  Caldwell, Patrina Hy ^a,b   Murphy, Sharon B ^c   Butow, Phyllis N ^b   Craig, Jonathan C ^a,b,d  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHILD; CLINICAL PRACTICE; CLINICAL RESEARCH; CLINICAL TRIAL; DECISION MAKING; FINANCIAL MANAGEMENT; FUTUROLOGY; HUMAN; INFORMATION PROCESSING; INFORMED CONSENT; MARKET; MEDICAL RESEARCH; METHODOLOGY; ONCOLOGY; PARENT; PHYSICIAN; POLICY; PRIORITY JOURNAL; RESEARCH ETHICS; REVIEW;

EID: 4444351808     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(04)16942-0     Document Type: Review

References (113)

1. Chessells JM. Treatment of childhood acute lymphoblastic leukemia: present issues and future prospects. Blood Rev. 6:1992;193-203
2. Wilson JT. An update on the therapeutic orphan. Pediatrics. 104:1999;585-590
3. Roberts R, Rodriguez W, Murphy D, Crescenzi T. Pediatric drug labeling. Improving the safety and efficacy of pediatric therapies. JAMA. 290:2003;905-911
4. Silverman WA, Andersen DH, Blanc WA, Crozier DN. A difference in mortality rate and incidence of kernicterus among premature infants allotted to two prophylactic antibacterial regimes. Pediatrics. 18:1956;614-625
5. Smyth RL, Weindling AM. Research in children: ethical and scientific aspects. Lancet 1999; 354 (suppl II): 2124.
6. Steinbrook R. Testing medications in children. N Engl J Med. 347:2002;1462-1470
7. World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. http://www.wma.net/e/policy/b3.html (accessed Mar 30, 2004).
8. Segelov E, Tattersall MHN, Coates AS. Redressing the balance: the ethics of not entering an eligible patient on a randomised clinical trial. Ann Oncol. 3:1992;103-105
9. World summit against cancer for the new millennium charter of Paris, Article III. Paris; 2000.
10. Rothman KJ, Michels KB. The continuing unethical use of placebo controls. N Engl J Med. 331:1994;394-398
11. Ellis PM, Butow PN, Simes RJ, Tattersall MHN, Dunn SM, MacLeod C. Doctors' participation in randomized trials of adjuvant systemic therapy in breast cancer: how does it relate to their recommendations for standard therapy in breast cancer? Breast. 8:1999;182-187
12. Vist GE, Hagen KB, Devereaux PJ, Oxman AD. Outcomes of patients who participate in randomised controlled trials versus those of similar patients who do not participate (protocol for a Cochrane methodology review). In: The Cochrane Library, Issue 4, 2001.
13. Schmidt B, Gillie P, Caco C, Roberts J, Roberts R. Do sick newborn infants benefit from participation in a randomized clinical trial? J Pediatr. 134:1999;151-155
14. Davis S, Wright PW, Schulman SF, et al. Participants in prospective, randomized clinical trials for resected non-small cell lung cancer have improved survival compared with nonparticipants in such trials. Cancer. 56:1985;1710-1718
15. American Academy of Pediatrics. Guidelines for the ethical conduct of studies to evaluate drugs in pediatrtic populations (RE9503). http://www.aap.org/policy/00655.html (accessed Mar 30, 2004).
16. Roland M, Torgerson DJ. Understanding controlled trials: what are pragmatic trials? BMJ. 316:1998;285
17. Miller FG, Wendler D, Wilfond B. When do the federal regulations allow placebo-controlled trials in children. J Pediatr. 142:2003;102-107
18. Ross LF. Do healthy children deserve greater protection in medical research? J Pediatr. 142:2003;108-112
19. Working party on research on children, MRC. The ethical conduct of research on children. December, 1991.
20. Peart N. Health research with children: the New Zealand experience. Curr Legal Issues. 3:2000;421-439
21. Royal College of Paediatrics and Child Health: ethics advisory committee - guidelines for the ethical conduct of medical research involving children. Arch Dis Child 2000; 82: 177-82.
22. Caldwell PHY, Butow PN, Craig JC. Parents' attitudes to randomised controlled trials involving children. J Pediatr. 145:2003;555-560
23. Botstein P. Why FDA is encouraging drug testing in children: FDA consumer special report, 1995. http://www.fda.gov/fdac/special/newdrug/kidmed.html (accessed Mar 30, 2004).
24. Simar MR. Pediatric drug development: the international conference on harmonization focus on clinical investigations in children. Drug Info J. 34:2000;809-819
25. National Institute of Health. NIH policy and guidelines on the inclusion of children as participants in research involving human subjects. http://grants.nih.gov/grants/guide/notice-files/not98-024.html (accessed April, 2004).
26. International Conference on Harmonisation. ICH topic E11 clinical investigation of medicinal products in the paediatric population. http://www.emea.eu.int/pdfs/human/ich/271199EN.pdf (accessed April, 2004).
27. Europa. Ethical Rules for FP6. http://europa.eu.int/comm/research/ science-society/ethics/rules_en.html (accessed Mar 30, 2004).
28. Position paper "Promotion of Paediatric Research in The European Union", 2002. http://www.efpia.org/4_pos/sci_regu/Paeds020123.pdf (accessed Mar 30, 2004).
29. National Health and Medical Research Council. http://www.health.gov.au/ nhmrc/ (accessed April, 2004)
30. RACP. Paediatric policy: ethics of research in children. http://www.racp.edu.au/hpu/paed/ethRes.htm (accessed April, 2004).
31. 107th Congress of the United States of America. Best pharmaceuticals for children Act, S. 1789 109. http://www.fda.gov/cder/pediatric/PL107-109.pdf (accessed Mar 30, 2004).
32. US Food and Drug Administration. Drug research and children. FDA Consumer Magazine, January-February, 2003. http://www.fda.gov/fdac/features/2003/ 103_drugs.html (accessed Mar 30, 2004).
33. Zimmerman R. Child play: pharmaceutical firms win big on plan to test adult drugs on kids. Wall Street Journal, Feb 5, 2001.
34. Jong GW, van den Anker J, Choonara I. FDAMA's Written request list: medicines for children. Lancet. 357:2001;398
35. United States Department of Health and Human Services. Statement by Tommy G Thompson, Secretary of Health and Human Services, and Mark B McClellan, Commissioner of Food and Drugs regarding passage of S.650: the Pediatric Research Equity Act of 2003. http://www.hhs.gov/news/press/2003pres/20030724. html (accessed Mar 30, 2004).
36. European Federation of Pharmaceutical Industries and Associations. Considerations in support of an effective proposal for medicinal products for paediatric use: European Federation of Pharmaceutical Industries and Associations, 2003.
37. Kauffman RE. Essential drugs for infants and children: North American perspective. Pediatrics. 104:1999;603-605
38. Ross LF, Walsh C. Minority children in pediatric research. Am J Law Med 2003.
39. Meaux JB, Bell PL. Balancing recruitment and protection: children as research subjects. Iss Comp Pediatr Nursing. 24:2001;241-251
40. Caldwell PHY, Butow PN, Craig JC. Paediatricians' attitudes to randomised controlled trials involving children. J Pediatr. 141:2002;798-803
41. Shuster E. Fifty years later: the significance of the Nuremburg Code. N Engl J Med. 337:1997;1436-1440
42. Broome ME. Children's assent to clinical trial participation: a unique kind of informed consent. http://www.cancer.gov/clinicaltrials/understanding/ childrensassent0101 (accessed Mar 30, 2004).
43. Cheney R, Hastert D. Protections for children in research: a report to Congress in accord with Section 1003 of P.L. 106-310, Children's Health Act of 2000. Washington DC, 2001.
44. Wendler D, Rackoff JE, Emanuel EJ, Grady C. The ethics of paying for children's participation in research. J Pediatr. 141:2002;166-171
45. Dobson R. Lump sums for children taking part in research may distort parents' judgement. BMJ. 325:2002;796
46. Weise KL, Smith MLMKJ, Copeland HL. National practices regarding payment to research subjects participating in pediatric research. http://www. findarticles.com/cf_dls/m0950/3_110/91560747/print.html (accessed Mar 30, 2004).
47. The European Parliament and the Council of the European Union. Directive 2001/20/EC of the European Parliament and of the Council of Apr 4, 2001, on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use. Directive 2001/20/EC, Article 4(d), 14EN-15EN. 4-4-0001.
48. Dickert N, Grady C. What's the price of a research subject? approaches to payment for research participation. N Engl J Med. 341:1999;198-203
49. ICH Steering committee. ICH harmonised tripartite guideline: guideline for good clinical practice E6. http://www.emea.eu.int/pdfs/human/ich/013595en. pdf (accessed April, 2004).
50. Kopelman LM. Children as research subjects: a dilemma. J Med Philos. 25:2000;745-764
51. Institute of Medicine, Committee on Assessing the System for Protecting Human Research Participants. Responsible research. Federman D, Hanna K, Roderiguez L, eds. National Academies Press, 2003.
52. Kaufman JL. Protecting research subjects. N Engl J Med. 346:2002;2093-2095
53. Janofsky J, Starfield B. Assessment of risk in research on children. J Pediatr. 98:1981;842-846
54. Miller FG, Rosenstein DL. The therapeutic orientation to clinical trials. N Engl J Med. 348:2003;1383-1386
55. Smith L, Byers JF. Gene therapy in the post-Gelsinger era. JONAS Healthc Law Ethics Regul. 4:2002;104-110
56. Turner S, Longworth A, Nunn AJ, Choonara I. Unlicensed and off label drug use in paediatric wards: prospective study. BMJ. 316:1998;343-345
57. Lamprill J. Trials of paediatric medicines: clinical research focus 1999; December.
58. Nahata MC. Licensing of medicines for children in the USA. Pediatric and perinatal drug therapy, May 1997. Priory Lodge Education Ltd, 1997.
59. Committee on Drugs, American Academy of Pediatrics. Guidelines for the ethical conduct of studies to evaluate drugs in pediatric populations. Pediatrics 1995; 95: 286-94.
60. Nordenberg N. Pediatric drug studies: protecting pint-sized patients. FDA Consumer Magazine 33, 1999.
61. Anderson BJ, Ellis JF. Common errors of drug administration in infants: causes and avoidance. Paediatr Drugs. 1:1999;93-107
62. Cohen SN. The Pediatric Pharmacology Research Unit (PPRU) Network and its role in meeting pediatric labeling needs. Pediatrics. 104:1999;644-645
63. Smyth RL. Research with children: paediatric practice needs better evidence - gained in collaboration with parents and children. BMJ. 322:2001;1377-1378
64. Campbell H, Surry SAM, Royle EM. A review of randomised controlled trials published in Archives of Disease in Childhood from 1982-96. Arch Dis Child. 79:1998;192-197
65. Ross LF. Salmeterol and inhaled corticosteroids in patients with persistent asthma. JAMA. 286:2001;3076
66. Bleyer WA. Re: recruiting minorities into clinical trials: toward a participant-friendly system. J Natl Cancer Inst. 88:1996;377
67. Collet JP, Floret D, Cochat P, et al. Group meetings for recruitment of children in a clinical trial. Therapie. 46:1991;139-142
68. Chessells JM, Bailey C, Richards SM. Intensification of treatment and survival in all children with lymphoblastic leukemia: results of UK Medical Research Council trial UKALL X. Lancet. 345:1995;143-148
69. Harth SC, Thong YH. Parental perceptions and attitudes about informed consent in clinical research involving children. Soc Sci Med. 41:1995;1647-1651
70. Morrow GR, Hickok JT, Burish TG. Behavioral aspects of clinical trials: an integrated framework from behavior theory. Cancer. 74:(suppl 9):1994;2676-2682
71. Taylor KM, Kelner M. Interpreting physician participation in randomized clinical trials: the Physician Orientation Profile. J Health Soc Behav. 28:1987;389-400
72. Fallowfield L, Ratcliffe D, Souhami R. Clinicians' attitudes to clinical trials of cancer therapy. Eur J Cancer. 33:1997;2221-2229
73. Taylor KM. Integrating conflicting professional roles: physician participation in randomized clinical trials. Soc Sci Med. 35:1992;217-224
74. Peto V, Coulter A, Bond A. Factors affecting general practitioners' recruitment of patients into a prospective study. Fam Pract. 10:1993;207-211
75. McCaskill-Stevens W, Pinto H, Marcus AC, et al. Recruiting minority cancer patients into cancer clinical trials: a pilot project involving the Eastern Cooperative Oncology Group and the National Medical Association. J Clin Oncol. 17:1999;1029-1039
76. Taylor KM, Margolese RG, Soskolne CL. Physicians' reasons for not entering eligible patients in a randomized clinical trial of surgery for breast cancer. N Engl J Med. 310:1984;1363-1367
77. Taylor KM. The doctor's dilemma: physician participation in randomized clinical trials. Cancer Treat Rep. 69:1985;1095-1100
78. Anon. Viability of cancer clinical research: patient accrual, coverage, and reimbursement. American Medical Association Council on Scientific Affairs. J Natl Cancer Inst 1991; 83: 0254-59.
79. Siminoff LA, Zhang A, Colabianchi N, Sturm CM, Shen Q. Factors that predict the referral of breast cancer patients onto clinical trials by their surgeons and medical oncologists. J Clin Oncol. 18:2000;1203-1211
80. Ellis PM, Butow PN, Simes RJ, Tattersall MHN, Dunn SM. Barriers to participation in randomized clinical trials for early breast cancer among Australian cancer specialists. Aust N Z J Surg. 69:1999;486-491
81. Taylor KM. Physician participation in a randomized clinical trial for ocular melanoma. Ann Ophthalmol. 24:1992;337-344
82. Taylor KM, Shapiro M, Soskolne CL, Margolese RG. Physician response to informed consent regulations for randomized clinical trials. Cancer. 60:1987;1415-1422
83. Benson AB, Pregler JP, Bean JA, Rademaker AW, Eshler B, Anderson K. Oncologists' reluctance to accrue patients onto clinical trials: an Illinois Cancer Center study. J Clin Oncol. 9:1991;2067-2075
84. Chang RW, Falconer J, Stulberg SD, Arnold WJ, Dyer AR. Prerandomization: an alternative to classic randomization - the effects on recruitment in a controlled trial of arthroscopy for osteoarthrosis of the knee. J Bone Joint Surg Am. 72:1990;1451-1455
85. Swanson GM, Ward AJ. Recruiting minorities into clinical trials: toward a participant-friendly system. J Natl Cancer Inst. 87:1995;1747-1759
86. Taylor KM, Feldstein ML, Skeel RT, Pandya KJ, Ng P, Carbone PP. Fundamental dilemmas of the randomized clinical trial process: results of a survey of the 1,737 Eastern Cooperative Oncology Group investigators. J Clin Oncol. 12:1994;1796-1805
87. Walterspiel JN. Informed consent: influence on patient selection among critically ill premature infants. Pediatrics. 85:1990;119-121
88. Tait AR, Voepel-Lewis T, Malviya S. Participation of children in clinical research, factors that influence a parent's decision to consent. Anesthesiology. 99:2003;819-825
89. Zupancic JAF, Gillie P, Streiner DL, Watts JL, Schmidt B. Determinants of parental authorization for involvement of newborn infants in clinical trials. Pediatrics. 99:1997;E6
90. Langley JM, Halperin SA, Mills EL, Eastwood B. Parental willingness to enter a child in a controlled vaccine trial. Med Clin Exp. 21:1998;12-16
91. Childhood Asthma Management Program Research Group. Recruitment of participants in the childhood asthma management program (CAMP). I. Description of methods. J Asthma 1999; 36: 217-37.
92. Hayman RM, Taylor CT, Peart NS, Galland BC, Sayers RM. Participation in research: informed consent, motivation and influence. J Pediatr Child Health. 37:2001;51-54
93. Thong YH, Harth SC. The social filter effect of informed consent in clinical research. Pediatrics. 87:1991;568-569
94. Levene M, Wright I, Griffiths G. Is informed consent in neonatal randomised controlled trials ritual? Lancet. 347:1996;475
95. Clinical Pharmacology and Therapeutics. Abstract from one hundredth annual meeting of the American Society for Clinical Pharmacology and Therapeutics. Children in research speak for themselves. Texas: Mosby, 1999.
96. Tercyak KPJ, Johnson SB, Kirkpatrick KA, Silverstein JH. Offering a randomized trial of intensive therapy for IDDM to adolescents. Reasons for refusal, patient characteristics, and recruiter effects. Diabetes Care. 21:1998;213-215
97. Tait AR, Voepel-Lewis T, Malviya S. Do they understand? (Part 1), Parental consent for children participating in clinical anesthesia and surgery research. Anesthesiol. 98:2003;603-608
98. Snowdon C, Garcia J, Elbourne D. Making sense of randomization; responses of parents of critically ill babies to random allocation of treatment in a clinical trial. Soc Sci Med. 45:1997;1337-1355
99. Wiley FM, Ruccione K, Moore IM, et al. Parents' perceptions of randomization in pediatric clinical trials. Cancer Pract. 7:1999;248-256
100. Featherstone K, Donovan JL. Random allocation or allocation at random? patients' perspectives of participation in a randomised controlled trial. BMJ. 317:2002;1177-1180
101. Welton AJ, Vickers MR, Cooper JA, Meade TW, Marteau TM. Is recruitment more difficult with a placebo arm in randomised controlled trials? A quasirandomised, interview based study. BMJ. 318:1999;1114-1117
102. Halpern SD, Ubel PA, Berlin JA, Townsend RR, Asch DA. Physicians' preferences for active-controlled versus placebo-controlled trials of new antihypertensive drugs. J Gen Intern Med. 17:2002;689-695
103. van Stuijvenberg M, Suur MH, de Vos S, et al. Informed consent, parental awareness, and reasons for participating in a randomised controlled study. Arch Dis Child. 79:1998;120-125
104. Tarnowski KJ, Allen DM, Mayall C, Kelly PA. Readability of pediatric biomedical research informed consent forms. Pediatrics. 85:1990;58-62
105. Stiller CA, Bunch KJ. Trends in survival for childhood cancer in Britian diagnosed 1971-85. Br J Cancer. 62:1990;806-815
106. National Cancer Institute. Cancer incidence and survival among children and adolescents: United States SEER Program, 1975-1995. Ries LAG, Smith MA, Gurney JG, et al, eds. Bethesda MD, 1999.
107. Ross JA, Severson RK, Pollock BH, Robison LL. Childhood cancer in the United States: a geographical analysis of cases from the pediatric cooperative clinical trials groups. Cancer. 77:1996;201-207
108. Murphy SB. The national impact of Clinical Cooperative Group Trials for pediatric cancer. Med Pediatr Oncol. 24:1995;279-280
109. Murphy SB. Cancer clinical trials: risks and benefits. J Pediatr Hematol Oncol. 3:2001;546-567
110. Ellis P. Improving recruitment to cancer clinical trials. Cancer Forum. 23:1999;153-155
111. Simone JV, Lyons J. The evolution of cancer care for children and adults. J Clin Oncol. 7:1998;2904-2905
112. The Medical Research Council General Practice Research Framework. http://www.mrc-gprf.ac.uk (accessed April, 2004).
113. National Cancer Institute. The Central Institutional Review Board Initiative. http://www.ncicirb.org (accessed Mar 30, 2004).